Enhancement of growth hormone activity in vivo by monoclonal antibodies: potential for autoimmunization.
Aston
R
R
CSIRO, Division of Molecular Biology, Sydney, Australia.
Holder
A T
AT
Wallis
M
M
Bates
P C
PC
Bomford
R
R
D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D004357:Drug Synergism; D004393:Dwarfism, Pituitary / Q000188:drug therapy* / Q000378:metabolism; D013006:Growth Hormone / Q000276:immunology / Q000494:pharmacology*; D007136:Immunoglobulins / Q000494:pharmacology; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D008221:Lymphoid Tissue / Q000378:metabolism; D051379:Mice; D008862:Microsomes, Liver / Q000378:metabolism; D051381:Rats; D011986:Receptors, Somatotropin / Q000378:metabolism / Q000502:physiology; D012756:Sheep
D000911:Antibodies, Monoclonal; D007136:Immunoglobulins; D011986:Receptors, Somatotropin; D007334:Insulin-Like Growth Factor I; D013006:Growth Hormone